fludarabine phosphate
- Product NDC
- 25021-237
- 11-digit product format
- 250210237
- Labeler code
- 25021
- Product ID
- 25021-237_18f5feab-3c38-40f5-a595-6a6c66762af2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fludarabine phosphate
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA076349
- Marketing category
- ANDA
- Marketing start
- 2014-12-15
- Marketing end
- 2020-06-30
- Substance
- FLUDARABINE PHOSPHATE
- Active strength
- 25 mg/mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record